Our comprehensive guide hospitals information helps you quickly locate a hospital anywhere in the world. Our database contains in excess of 16,000 hospitals, making it one of the best places to find information on the hospital you are searching for. To assist you with locating a hospital, you can refine your search by selecting the country in which the hospital is located and choose to search by either hospital name, city/town or state/county.

 Home>> Clolar (clofarabine)

Clolar (clofarabine)

General Information

Clolar (clofarabine) is an anti-neoplastic purine nucleoside analog used to treat lymphoblastic leukemia . The drug acts as an anti-metabolite, interfering with DNA replication. In addition, the drug appears to disrupt the integrity of the mitochondrial membrane, releasing pro-apoptotic mitochondrial proteins, cytochrome C and apoptosis-inducing factor, activating pathways of programmed cell death. In these ways Clolar exerts a cytotoxic effect on both rapidly dividing and quiescent cancer cells.

Clolar is specifically indicated to treat acute lymphoblastic leukemia (ALL) in pediatric patients ages 1-21, whose disease has relapsed or beecome refractory after at least two prior treatment regimens.

Clolar is administered as an intravenously, with a recommended dosage of 52 mg/m2 via 2-hour infusion dialy for 5 days, with cycle repeats every 2-6 weeks once organ function has returned to baseline.


Additional Information

For additional information regarding Clolar or acute lymphoblastic leukemia, please visit the Genzyme Oncology web page.


Clinical Results

FDA approval of Clolar was based on a pair of clinical trials, involving a total of 66 pediatric ALL patients. The first was a open-label, dose-escalation, noncomparative study, which enrolled a total of 17 pediatric ALL patients . Subjects received escalating doses of the drug ranging from 11.25 mg/m2 to 70 mg/m2, daily for 5 days. 9 of the 17 received the recommended dose of 52 mg/m2. Among all patients 2 complete and 2 patial responses were observed. Dose limiting toxicities, including reversible hyperbilirubinemia and elevated transaminase levels and skin rash, were observed at 70 mg/m2, leading to the choice of 52 mg/m2 as the optimum dose.

The second study was a single arm, open label study which enrolled 49 pediatric ALL patients. Subjects in this study received up to sequential cycles at the recommended dose (52 mg/m2 x 5 days), with no dose escalation. Efficacy was observed in the trial's primary endpoint, the overall rate of response. Specifically, there were 6 completer responses (CR; 12.2%), 4 complete responses which did not also demonstrate platelet recovery (CRp; 8.2%), and 5 partial responses (PR; 10.2%), for a total response rate of 30.6%. Among the 9 responding patients who did not undergo bone marrow transplant following treatment, response durations were as follows: 43, 50, 82, 93+ and 160+ days for CR subjects, 32 days for one CRp subject, and 7, 16, and 21 days for PR subjects.


Mechanism of Action

Clolar disrupts DNA synthesis and causes fatal replication errors through the disruption of several intracellular syntetic pathways. Specifically, the drug depletes deoxynucleotide triphosphate pools through the inhibition of ribonucleotide reductase, and causes termination of DNA chain elongation through incorporation into the DNA strand and competitive inhibition of DNA polymerases. Furthermore, the drug has been shown to disrupt mitochondrial membrane intergrity, possibly through disruption of mitochondrial DNA synthesis. Disruption of mitochondrial integrity leads to the release of the pro-apoptotic mitochondrial proteins, cytochrome C and apoptosis-inducing factor, which activate programmed cell death pathways.


Literature References

Side effects

Adverse events associated with the use of Clolar may include (but are not limited to) the following:


  • Febrile neutropenia
  • Systemic Inflammatory Response Syndrome (SIRS)
  • Vomiting
  • Nausea
  • Diarrhea
  • Pyrexia
  • Rigors
  • Abdominal Pain
  • Fatigue
  • Tachycardia
  • Anorexia Additionally, animal models have demostrated teratogenic potential in pregnant women. Human embryo toxicity has not been investigated, but the likelyhood of risk to the fetus is very high, and pregnancy should be avoided while receiving Clolar.

Treatment

Lymphoblastic Leukemia

Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prozac Weekly (fluoxetine HCl) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Neulasta Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Alphagan (brimonidine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Rhinocort Aqua Nasal Spray Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Amerge Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Dynabac Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Rytary (carbidopa and levodopa) extended-release capsules Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Paxil (paroxetine hydrochloride) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Qvar (beclomethasone dipropionate) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Cetrotide Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Lupron Depot (leuprolide acetate for depot suspension) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Pindolol Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Atracurium Besylate Injection Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Carnexiv (carbamazepine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Celexa Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Asacol (mesalamine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Verapamil Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Olysio (simeprevir) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prograf Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Bio-T-Gel (testosterone gel) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Alora Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Onglyza (saxagliptin) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Orbactiv (oritavancin) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Rebif (interferon beta-1a) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prometrium Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Argatroban Injection Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Remodulin (treprostinil) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Onfi (clobazam) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Altocor (lovastatin) Extended-Release Tablets Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Pulmozyme (dornase alfa) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print REPRONEX(menotropins for injection, USP) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Prilosec (omeprazole)/Biaxin (clarithromycin) Combination Therapy Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Retin-A Micro (tretinoin gel) microsphere, 0.1% Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Cleocin (clindamycin phosphate) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Periostat (doxycycline hyclate) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Omnicef Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Avonex (Interferon Beta 1-A) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Anthim (obiltoxaximab) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Zerit (stavudine) Select an option ICD-9 and ICD-10 ICD-9CM ICD-10CM Back News | Share | Print Ranexa (ranolazine)